Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cheaper alternative may work just as well in Kids' heart surgery

NCT ID NCT06792565

First seen Dec 29, 2025 · Last updated Jun 19, 2026 · Updated 30 times

Summary

This study looked at 60 children aged 1 to 15 having heart surgery with a heart-lung machine. It compared two devices—hemofilters and hemodialyzers—to see how well they remove inflammatory substances called cytokines. The goal is to find a safe, cost-effective option for hospitals with limited resources.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONGENITAL HEART DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Alnas Hospital

    Shubrā al Khaymah, Egypt

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could show that hemodialyzers are a safe and effective alternative to hemofilters, potentially reducing costs in low-resource countries.

What could go wrong

This is a small, completed study with only 60 children, so results may not apply to all patients. It measures temporary changes during surgery, not long-term outcomes.

Conditions

The condition(s) this trial relates to.

congenital heart disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.